Acrivon Therapeutics Inc.... (ACRV)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.59
0.03 (0.54%)
At close: Jan 15, 2025, 2:10 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -1.8 | -8.51 | -21.37 | -65.42 |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 0.90 | 1.48 | -14.58 | -41.26 |
P/FCF Ratio | -2.47 | -7.82 | -24.41 | -123.18 |
P/OCF Ratio | -2.55 | -8.38 | -24.83 | -123.83 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.03 | -0.24 | -0.01 |
Quick Ratio | 9.75 | 19.61 | 34.46 | 2.80 |
Current Ratio | 9.75 | 19.61 | 34.46 | 2.80 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.5 | -0.17 | 0.68 | 0.63 |
Return on Assets (ROA) | -0.44 | -0.16 | -0.15 | -2.43 |
Return on Capital (ROIC) | -0.54 | -0.19 | -0.16 | -2.02 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |